We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biomarker Helps Predict Stomach Cancer Survival

By LabMedica International staff writers
Posted on 16 Sep 2015
Print article
Image: Histopathology of advanced gastric carcinoma of the intestinal type shows gland-forming adenocarcinoma and adjacent intestinal metaplasia (Photo courtesy of Drs. Shabnam Bashir and Sudip Raina).
Image: Histopathology of advanced gastric carcinoma of the intestinal type shows gland-forming adenocarcinoma and adjacent intestinal metaplasia (Photo courtesy of Drs. Shabnam Bashir and Sudip Raina).
A biomarker has been identified in patients with stomach cancer that starves tumors of their blood supply and reduces the ability of cancer cells to spread to other parts of the body.

In the USA, stomach cancer, also known as gastric cancer, most commonly affects older people, as around 60% of those diagnosed each year are over 65. Stomach cancer is most common in less developed countries, and it is a primary cause of cancer-related deaths worldwide.

Scientists at the Southern Medical University (Guangzhou, China) used a form of genetic analysis called quantitative real-time polymerase chain reaction (qRT-PCR) to detect micro ribonucleic acid 506 (miR-506) in human gastric samples taken from 84 people who had undergone cancer surgery. The team analyzed the miR-506 levels in each of these samples, and patients were allocated to different groups based on whether they were above or below the mean miR-506 level.

They found that miR-506 expression was a useful marker for stratifying patients from early to advanced clinical stages and for overall survival prediction. Overexpression of miR-506 inhibited the epithelial-to-mesenchymal transition of gastric cancer cells; however, depletion of miR-506 promoted it. In addition, miR-506 suppressed gastric cancer angiogenesis and was associated with decreased matrix metalloproteinase-9 expression. They also found that V-Ets Avian Erythroblastosis virus E26 Oncogene Homolog 1 (ETS1) was a miR-506 target, and it was expressed in 71.10% of gastric cancer tissue samples. At 60 months, cumulative survival was approximately 30% in the low-miR-506 expression group, compared with 80% in the high-expression group.

The team then looked at signs of miR-506 in seven stomach cancer cell lines. Here, it was found that stomach cancer cells had lower levels of miR-506 than normal stomach tissue. Analysis of cells grown in vitro then showed that miR-506 levels were lowest in the cell lines that had the highest invasive activity, and the highest levels were seen in cell lines with the lowest invasive activity.

Xin Song, MD, PhD, the lead investigator, said, “Our findings indicate that miR-506 is necessary and sufficient for angiogenesis suppression during gastric cancer progression. Cancer is a complex disease and controlling cancer development and progression requires system level and integrative approaches. Our study suggests that miR-506 acts as a tumor suppressor in gastric cancer." The study was published on September 8, 2015, in the American Journal of Pathology.

Related Links:

Southern Medical University 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.